Estimated reading time: 6 minutes · Last updated:
CB Insights released its 2026 Insurtech 50 in September 2026. The list includes ten firms based in Europe. Together, the 50 winners have secured US$3 billion in equity, roughly US$800 million of which was raised so far in 2026; they employ more than 5,400 people with a median headcount of 52. This briefing profiles nine Europe-headquartered insurtechs highlighted in the list — Akur8, Alan, Artificial Labs, Kota, Ominimo, Diesta, Tuio, Liablix and Vantel — and summarises the funding, customer scale and AI-driven products that mark the cohort.
Key takeaways
- The 2026 Insurtech 50 features ten Europe-based firms and highlights AI adoption and specialist product strategies as notable trends.
- Across the cohort, equity funding totals US$3 billion, with roughly US$800 million raised this year to date.
- Alan claims more than EUR 800 million in annual recurring revenue (ARR) and raised EUR 480 million in June 2026 at a EUR 5.5 billion valuation.
- Ominimo serves nearly one million customers, reports an annual business volume exceeding US$350 million, and raised US$22.5 million at a US$1.6 billion valuation in July 2026.
- Akur8 serves over 350 customers across 40 countries and more than 3,000 actuaries use its platform daily.
Table of contents
What the Insurtech 50 reveals about scale and stage
The 50 insurtech winners were chosen in September 2026 based on factors such as deal volume, strategic partnerships, investor backing, hiring momentum, revenue, commercial performance and a Mosaic Score. Collectively the winners have attracted US$3 billion in equity, roughly US$800 million of that raised so far in 2026, and together employ more than 5,400 people with a median headcount of 52. These aggregate figures indicate both concentrated capital and a broad early-stage base.
The cohort's composition underlines that the market remains young: 31 of the 50 are early-stage startups and 14 are at the seed stage, which means many companies still need to prove unit economics and distribution beyond pilot partnerships. At the same time, the list includes companies that have scaled commercially and closed major rounds or strategic deals, creating a mix of fast-growth and high-risk profiles within the same ranking.
For incumbents and buyers that track innovation, the numeric mix matters: substantial funding and hiring momentum make follow-on rounds and M&A more likely, while the prevalence of early-stage companies points to structural churn as winners and losers emerge.
Nine European winners: what each brings
Akur8 (Paris) offers an actuarial platform used by more than 3,000 actuaries and serves over 350 customers across 40 countries, targeting P&C and life and annuity pricing and reserving. Alan (France) operates a digital health-insurance and care platform that serves over 1.1 million members and 37,000 businesses, claims more than EUR 800 million in ARR, and closed a EUR 480 million round in June 2026 at a EUR 5.5 billion valuation.
Artificial Labs (London) supplies broking and underwriting technology for specialty and commercial lines and raised a US$45 million Series B in February 2026 to accelerate global growth. Kota (Dublin) is embedded benefits infrastructure powering benefits for over 100,000 employees and reported a two-year compound annual revenue growth rate of 640.35%, an indicator of rapid commercial traction.
Ominimo (Budapest) is a digital car insurer that says it serves nearly one million customers and reports an annual business volume exceeding US$350 million; it raised US$22.5 million in July 2026 at a US$1.6 billion valuation and plans further EU and US expansion. Diesta (London) builds an agentic payments layer and announced an August 2026 partnership with Instanda to connect policy administration to premium collection and reconciliation. Tuio (Spain) has more than 100,000 active customers and Mapfre acquired 38.9% of Tuio’s capital in July 2026 to support geographic expansion. Liablix (Bologna), founded in 2025, applies physics, 3D reconstruction and computer vision to road-accident analysis, and Vantel (Stockholm), founded in 2024, provides AI automation for commercial brokerages.
Technology and product specialisation driving selection
AI and adjacent technologies recur across the winners: computer vision, 3D reconstruction, geospatial modelling and voice analytics appear in multiple offers. AI is relevant for all of these winners, from underwriting and claims automation to distribution and payments, and firms are positioning narrow, specialist products rather than generalist platforms.
Examples from the selection illustrate the range: Artificial Intelligence Underwriting Company closed a US$40 million Series A in September 2026; Delos applies geospatial modelling and satellite imagery to underwrite wildfire risk; Clearspeed provides automated voice-based risk assessment to triage claims; Odin Space deploys Nano Sensors to verify orbital-debris impacts. These specialist technologies sharpen product differentiation but introduce specific integration and compliance challenges.
The technical demands—model validation, sensor calibration, satellite data licensing and voice-forensics—mean insurers will need engineering partnerships and operational controls as much as vendor contracts.
Commercial pathways and the risks ahead
Several winners are scaling via partnerships and distribution deals: the cohort disclosed more than 70 partnerships since 2025, and strategic investments such as Mapfre’s stake in Tuio show incumbents buying exposure to digital-first propositions. That route can accelerate growth, but it also concentrates counterparty and integration risk.
Nearly two-thirds, 31 of the 50, remain early-stage companies, so additional financing and regulatory clearances will be important next steps for many. Rapid expansion plans, such as Ominimo's push into multiple EU markets and the US, increase demands on regulatory compliance and capital readiness, according to company communications.
For buyers, the operational trade-off is clear: specialist insurtechs can plug capability gaps quickly, but they increase dependency on vendors and on the performance of nascent AI models, creating execution risk over the medium term.
| Company | Headquarters | Focus | Key figure(s) |
|---|---|---|---|
| Akur8 | Paris, France | Actuarial pricing and reserving platform | over 350 customers across 40 countries; 3,000+ actuaries |
| Alan | France | Digital health insurance and care platform | 1.1 million members; EUR 800M ARR; EUR 480M raise (Jun 2026) |
| Artificial Labs | London, UK | Digital broking and underwriting tech | US$45M Series B (Feb 2026) |
| Kota | Dublin, Ireland | Embedded benefits and employee perks infrastructure | powers benefits for 100,000+ employees; 640.35% two-year CAGR |
| Ominimo | Budapest, Hungary | AI-priced digital car insurance | nearly 1 million customers; >US$350M annual volume; US$22.5M Series B (Jul 2026) |
| Diesta | London, UK | Agentic payments infrastructure for insurers | Partnership with Instanda (Aug 2026) |
| Tuio | Spain | App-managed home, car and life insurance | 100,000+ customers; Mapfre acquired 38.9% (Jul 2026) |
| Liablix | Bologna, Italy | Accident analysis with 3D reconstruction and computer vision | founded 2025 |
| Vantel | Stockholm, Sweden | AI automation for commercial insurance brokerages | founded 2024 |
Near-term case for and against the cohort
The case for
- Specialist AI products and sensor-based services create clear go-to-market differentiation with incumbents that need narrow capabilities.
- Strong funding and hiring momentum — US$3 billion in equity funding across the cohort and about US$800 million in 2026 so far — supports follow-on growth and geographic expansion.
- Partnership activity (70+ disclosed since 2025) offers fast distribution channels and incumbent validation.
The case against
- High concentration of early-stage companies (31 of 50) increases the risk of follow-on funding shortfalls and consolidation.
- Cross-border expansion and regulatory readiness, flagged by companies such as Ominimo, add compliance and capital requirements that can slow growth.
- Dependence on nascent AI models and specialised sensors raises model-risk and operational-integration exposures for buyers.
What to be careful about
- Follow-on funding risk for early-stage winners: 31 of the 50 are early-stage and 14 are at seed, increasing the chance of failed scale-ups.
- Regulatory and capital-readiness risk for rapid geographic expansion, as noted in Ominimo’s stated plans and regulatory initiatives.
- Model and vendor concentration risk from dependence on AI, computer vision and third-party sensor data for underwriting and claims.
The bottom line
The 2026 Insurtech 50 highlights a cohort where heavy investment and AI-driven specialisation coexist with a large early-stage population. European winners range from deep actuarial platforms like Akur8 to digital carriers such as Ominimo and app-first insurers like Tuio, with Alan standing out for scale in health coverage. For incumbents, the immediate task is selective adoption: partner where a specialist fills a clear capability gap, but expect vendor consolidation as early-stage companies seek follow-on capital or exit. For investors and buyers, the numeric signals — US$3 billion raised across the cohort, about US$800 million in 2026, and 31 early-stage firms — define an opportunity set that combines fast innovation with execution risk.
What to watch
- Watch Ominimo’s planned roll-out in Belgium and Romania and its subsequent expansion into Spain, Italy and France; no public dates have been set.
- Watch Diesta and Instanda’s client integrations and any public timelines for premium-collection rollouts following their August 2026 partnership; no public schedule has been set.
- Watch Alan’s product and market expansion funded by its June 2026 EUR 480 million round; no public launch dates have been set.
Frequently asked questions
How many Europe-based firms are on CB Insights' 2026 Insurtech 50?
The Insurtech 50 lists ten firms headquartered in Europe; this briefing focuses on nine of those companies.
How much funding have the Insurtech 50 winners raised?
Together, the 50 winners have raised US$3 billion in equity, about US$800 million of which was raised in 2026 to date, according to the Insurtech 50 data.
Which European insurtech on the list reports the largest ARR?
Alan claims more than EUR 800 million in annual recurring revenue (ARR) and completed a EUR 480 million funding round in June 2026 at a EUR 5.5 billion valuation.
Related reading
This article is information, not financial advice. Anyone acting on it should do their own checks.
